5 Underperforming Stocks Targeted By Short Sellers

4. Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC)

Short % of Float (Jan 14, 2021): 20.17%

Short % of Shares Outstanding (Jan 14, 2021): 19.99%

New Jersey-based Cyclacel claims to be developing “mechanism-targeted drugs” to treat cancer, diabetes and HIV. The company was founded in 1996 by David Lane, Merlin Ventures and Cancer Research Campaign Technology with the University of Dundee and the University of Glasgow.

Cyclacel shares are down 46% over the last 12 months.  Hal Mintz’s Sabby Capital owns 125,578 shares of the company, worth $458,000.